Physicians Brave Covid to Attend Axonics Modulation Technologies Inc. (AXNX) Seminar, Bodes Well for r-SNM - Needham
Tweet Send to a Friend
Needham & Company analyst Mike Matson reiterated a Buy rating and $78.00 price target on Axonics Modulation Technologies Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
